Introduction {#s1}
============

The prevalence of allergic diseases has experienced an important increase in industrialized countries over recent decades. Although this increase has been widely investigated, the reasons for such trend have not yet been elucidated [@pone.0107921-Pastorino1], [@pone.0107921-DeSario1]. According to the World Allergy Organization [@pone.0107921-World1], children carry the greatest burden of the rising trend which has occurred over the past two decades. Despite this increase, in many countries there are no specialized services for patients with allergic diseases.

In respiratory allergies, such as asthma and rhinitis, there is inflammation of the airways as a result of an immune reaction, with release of cytoplasmic granules from active substances found in mast cells, basophils, and eosinophils [@pone.0107921-Wallaert1], [@pone.0107921-Bush1]. Two main factors contribute to the development and severity of allergic disease: host-related (genetic) factors and environmental factors, such as specific allergens, elements present in the environment, and air pollutants. When combined, these factors may trigger sensitization [@pone.0107921-Peden1], [@pone.0107921-Sarinho1].

In addition, there is the "hygiene hypothesis", which became popular in the late 1980s to explain the high prevalence of atopic diseases in developed countries. It supports the idea that a reduced exposure to infections during childhood would predispose individuals to sensitization [@pone.0107921-Kim1], [@pone.0107921-Romagnani1], [@pone.0107921-Yazdanbakhsh1].

Since the mid-1960s, dust mites have been associated with allergic processes and identified as a causative agent of airway diseases, being considered one of the most important sources of allergens for humans. Among asthmatic patients, sensitivity to dust mites is present in 50% of adults and 80% of children [@pone.0107921-Atambay1], [@pone.0107921-Ertabaklar1]. The term "house dust mite" has been adopted to describe mite species that can be found in the indoor environment and have the ability to elicit a response resulting in IgE antibodies [@pone.0107921-FernandezCaldas1].

The study of cytokines and sensitivity to dust mites is intended to corroborate the understanding of this relationship, given the high incidence of positive skin reactions to *Dermatophagoides pteronyssinus*, *D. farinae*, and *Blomia tropicalis* that has been commonly reported in the literature. It is noteworthy that these species belong to the class of arachnids (class Arachnida, subclass Acarina) [@pone.0107921-MoralesdeLen1], [@pone.0107921-MedeirosJunior1], [@pone.0107921-MartnezJimnez1] and have glycoproteins capable of inducing an anaphylactic response. However, little is known about the mechanism of action of these allergens against the development of immune response in certain individuals [@pone.0107921-Petersen1], [@pone.0107921-Weber1].

Given the key role of cytokines in allergic reactions, gene variability in their regulatory regions might induce changes in the immune response [@pone.0107921-Read1]. Regulatory regions have shown an influence on cytokine production and transcription [@pone.0107921-Meenagh1], [@pone.0107921-Pravica1], [@pone.0107921-Fishman1], [@pone.0107921-Turner1]. Cytokines participate not only in the regulation of the immune response, but also directly in the inflammatory response [@pone.0107921-VanDerMeide1]. There are pro-inflammatory cytokines (tumor necrosis factor alpha \[TNF-α\], interleukin \[IL\]-1 alpha \[IL-1α\], IL-1 beta \[IL-1β\], IL-2, IL-6, and interferon \[IFN\] gamma \[IFN-γ\]) and anti-inflammatory cytokines (IL-4, IL-10, tumor growth factor beta-1 \[TGF-β1\], and INF beta \[IFN-β\]) [@pone.0107921-Cianciarullo1], [@pone.0107921-Blanger1], [@pone.0107921-Cerwenka1].

The involvement of interleukins in the pathogenesis of a range of diseases, such as lupus erythematosus, diabetes, chronic periodontitis, and cancer, has been widely studied. However, little is known about the association between single nucleotide polymorphisms (SNPs) in cytokine genes and sensitivity to dust mites. Therefore, we conducted a genetic association study to investigate markers of immune response in polymorphic variants of cytokine genes *IL1A* ^−889^ (rs1800587), *IL1B* ^−511,\ +3962^ (rs16944, rs1143634), *IL1R* ^1970^ (rs2234650), *IL1RA* ^11100^ (rs315952), *IL4RA* ^+1902^ (rs1801275), *IL12* ^−1188^ (rs3212227), *IFNG* ^+874^ (rs2430561), *TGFB1* ^codon\ 10,\ codon\ 25^ (rs1982073, rs1800471), *TNFA* ^−308,\ −238^ (rs1800629, rs361525), *IL2* ^−330,\ +166^ (rs2069762, rs2069763), *IL4* ^−1098,\ −590,\ −33^ (rs2243248, rs2243250, rs2070874), *IL6* ^−174,\ nt565^ (rs1800795, rs1800797), and *IL10* ^−1082,\ −819,\ −592^ (rs1800896, rs1800871, rs1800872) in mite-sensitive patients compared to mite-insensitive controls.

Materials and Methods {#s2}
=====================

Ethical considerations {#s2a}
----------------------

This study was approved by the Research Ethics Committee of Universidade Estadual de Maringá (protocol no. 693/2009) and conducted in accordance with the provisions of the Declaration of Helsinki. Educators and children from "Lar Escola de Maringá" and "Sistema de Apoio à Saúde São Rafael", two local public institutions providing child care and health care respectively, were invited to participate in the study. All participants completed a registration form, were adequately informed about the project, and provided written informed consent prior to their inclusion in the study. In the case of minors, under 18 years of age, written consent was obtained from their parents/legal guardian.

Sample size {#s2b}
-----------

Sample size calculation was based on city demographic data from the 2013 Census, with a population of 386,000 inhabitants. Assuming a 10% margin of error, maximum prevalence of 50% and 95% confidence interval, a minimum sample of 96 participants (cases) was required. Considering a possible loss of 10%, the final sample size was estimated at 138 participants (cases). Controls were defined according to the approximate number of cases, totaling 116 participants. Sample size was calculated using Statdisk version 8.4 [@pone.0107921-Triola1].

Inclusion and exclusion criteria {#s2c}
--------------------------------

The study included all children and educators who voluntarily agreed to participate in the study.

Characterization of the sample {#s2d}
------------------------------

Blood samples (10 ml) were drawn from 138 mite-sensitive and 116 mite-insensitive individuals, with a mean age of 12.9±7.6 years (range, 4--48 years), including 138 females and 116 males. Blood samples were collected into tubes containing EDTA anticoagulant.

Allergy testing {#s2e}
---------------

A skin prick test (Prick Test) was used to check for immediate sensitization to antigens specific for dust mites. The participants were tested for the following allergens: *Dermatophagoides farinae*, *Dermatophagoides pteronyssinus*, and *Blomia tropicalis*. Dust mite and control extracts were applied at a distance of 2 cm from each other in a predetermined order. A lancet was used to gently prick the extracts onto the skin surface. Reactions were read after 15--20 min by two independent readers, and the size of the wheal or erythema was the classification criterion for the degree of allergic reaction. A reaction was recorded as positive if the diameter of the wheal or erythema was ≥5 mm and negative in the absence of these signs.

Biological samples {#s2f}
------------------

Blood samples were centrifuged at 2500 rpm for 20 min to obtain the nucleated cell layer (buffy-coat), from which DNA was extracted using the commercial kit BIOPUR according to the manufacturer\'s instructions.

Genotyping of polymorphic variants in cytokine genes {#s2g}
----------------------------------------------------

A NanoDrop (2000c/2000 UV-Vis) spectrophotometer was used to evaluate DNA purity and adjust its concentration. The polymerase chain reaction-sequence specific primer (PCR-SSP) technique was used to genotype allelic variants in cytokine genes, using a commercially available genotyping kit. The method consists of a sequence of specific primers capable of amplifying the product (or not) based on the presence (or absence) of SNP in each well. According to information provided by the manufacturer, in addition to determining genotypes, it is also possible to define the haplotypes of *TGFB1*, *TNFA*, *IL2*, *IL4*, *IL6*, and *IL10*. The 22 selected SNPs are listed in [Table 1](#pone-0107921-t001){ref-type="table"}, including chromosomal locations and associated diseases as reported in previous studies.

10.1371/journal.pone.0107921.t001

###### Cytokine genes associated with different diseases as reported in previous studies.

![](pone.0107921.t001){#pone-0107921-t001-1}

  Gene                      SNP      Chromosomal location                                                                       Diseases
  --------------------- ----------- ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------
  *IL1A^−889^*           rs1800587           2q14                                                         Irritant contact dermatitis [@pone.0107921-Landeck1]
  *IL1B^−511^*            rs16944            2q14                                                        Susceptibility to asthma [@pone.0107921-PadrnMorales1]
  *IL1B^+3962^*          rs1143634           2q14                                                    Chronic periodontitis [@pone.0107921-AtanasovskaStojanovska1]
  *IL1R^1970^*           rs2234650           2q14                                                          Pulmonary tuberculosis [@pone.0107921-Amirzargar1]
  *IL1RA* ^11100^        rs315952           2q14.2                                                       Systemic lupus erythematosus[@pone.0107921-Tahmasebi1]
  *IL4RA* ^+1902^        rs1801275      16p12.1-p11.2                                                                Eczema [@pone.0107921-Miyake1]
  *IL12* ^−1188^         rs3212227       5q31.1-q33.1                                                                 Asthma [@pone.0107921-Chen1]
  *IFNG* ^+874^          rs2430561          12q14                                                       Severe acute respiratory syndrome [@pone.0107921-Chong1]
  *TGFB1* ^codon\ 10^    rs1982073         19q13.1                                                   Chronic obstructive pulmonary disease [@pone.0107921-Celedn1]
  *TGFB1* ^codon\ 25^    rs1800471         19q13.1                                      Dust mite exposure and disease severity in children with asthma [@pone.0107921-Sharma1]
  *TNFA* ^−308^          rs1800629          6p21.3                                                     Chronic irritant contact dermatitis [@pone.0107921-Jongh1]
  *TNFA* ^−238^          rs361525           6p21.3                                                         Chronic rhinosinusitis[@pone.0107921-MfunaEndam1]
  *IL2* ^−330^           rs2069762         4q26-q27                                                         Allergic disorders [@pone.0107921-Christensen1]
  *IL2* ^+166^           rs2069763         4q26-q27                    Lupus erythematosus; type 1 diabetes; cancer risk [@pone.0107921-Lin1], [@pone.0107921-Howson1], [@pone.0107921-Hussain1]
  *IL4* ^−1098^          rs2243248          5q31.1                                        Allergic rhinitis and association with clinical phenotypes [@pone.0107921-Movahedi1]
  *IL4* ^−590^           rs2243250          5q31.1                              Atopic asthma and allergic rhinitis; asthmatic children [@pone.0107921-Micheal1], [@pone.0107921-Baye1]
  *IL4* ^−33^            rs2070874          5q31.1                                                    Atopic asthma and allergic rhinitis [@pone.0107921-Micheal1]
  *IL6* ^−174^           rs1800795           7p21           Hypertension; type 2 diabetes; systemic-onset juvenile chronic arthritis [@pone.0107921-Jeng1], [@pone.0107921-Illig1], [@pone.0107921-Fishman2]
  *IL6* ^nt565^          rs1800797           7p21                                                           Coronary artery disease [@pone.0107921-Maitra1]
  *IL10* ^−1082^         rs1800896         1q31-q32                Dust mite exposure in allergy and asthma exacerbations; food allergy [@pone.0107921-Hunninghake1], [@pone.0107921-CamposAlberto1]
  *IL10* ^−819^          rs1800871         1q31-q32                                            Inflammatory and infectious respiratory diseases [@pone.0107921-Chelluri1]
  *IL10* ^−592^          rs1800872         1q31-q32                                                            Cow\'s milk allergy [@pone.0107921-Jacob1]

SNP  =  single nucleotide polymorphism.

Each DNA sample, adjusted to a concentration of 20 to 200 ηg/µL, was added to the amplification solution provided in the kit, along with the Taq DNA polymerase enzyme, according to the volumes recommended by the manufacturer.

After the solution was homogenized, aliquots were poured onto polyethylene plates containing 48 wells with specific primers. Plates were then transferred to a thermal cycler for gene amplification, according to the manufacturer\'s instructions.

Fragments of the amplified DNA were separated by electrophoresis in a micro SSP gel System in a 3% gel solution and homogenized with 2 µL of SYBR safe stain at 90 volts for 15 min. DNA bands exposed to ultraviolet light were visualized by SYBR staining and the results were interpreted based on the presence or absence of the specific fragment of DNA. All 48 wells had an internal control of known size as informed by the manufacturer. The samples were photo-documented for reading of results.

Statistical analysis {#s2h}
--------------------

Allele, genotype and haplotype frequencies were determined by direct counting. Observed and expected frequencies of patients and controls were compared using a 2×2 contingency table. The significance of differences in allele, genotype and haplotype frequencies was evaluated using two-tailed Fisher\'s exact test with Yates\' correction, followed by Bonferroni correction. The risk of developing sensitivity to dust mites was calculated by determining odds ratio (OR), according to Woolf [@pone.0107921-Woolf1], using Epi Info version 7. Hardy-Weinberg equilibrium (HWE) was tested using the method described by Guo and Thompson [@pone.0107921-Guo1] with the Arlequin software version 3.0 (<http://cmpg.unibe.ch/software/arlequin3>) [@pone.0107921-Excoffier1]. An age- and sex-adjusted logistic regression analysis was performed using SAS version 9.1 [@pone.0107921-Barr1]. The level of significance for all analyses was set at p\<0.05.

Results {#s3}
=======

The frequency of cases (atopic individuals) and controls (non-atopic individuals) in males was 48.5% (67/138) and 42.2% (49/116) respectively. The logistic regression analysis showed no difference between males and females (p = 0.1579). As for age, the group of allergic individuals had a mean age of 13.9±8.5 years (range, 4--48 years), while controls had a mean age of 11.7±6.4 years (range, 5--37 years). According to the regression analysis, individuals aged 13--18 years were 2.75 times and those aged \>18 years were 2.22 times more likely to be allergic (p = 0.0097 and p = 0.0358, respectively) than individuals under 12 years of age. The highest prevalence of allergy was observed in patients aged 13--18 years ([Table 2](#pone-0107921-t002){ref-type="table"}).

10.1371/journal.pone.0107921.t002

###### Results of age- and sex-adjusted logistic regression analysis.

![](pone.0107921.t002){#pone-0107921-t002-2}

                 Participants                                   
  ------------- -------------- ----- ------ ------ ------------ -----------------------------------------
  Age (years)                                                   
  ≤12                 86        178   48.3   Ref                
  13--18              27        38    71.1   2.75   1.28--5.92   0.0097[\*](#nt103){ref-type="table-fn"}
  \>18                25        38    65.8   2.22   1.06--4.65   0.0358[\*](#nt103){ref-type="table-fn"}
  Sex                                                           
  Male                67        116   57.8   Ref                
  Female              71        138   51.4   0.69   0.41--1.15                   0.1579

OR  =  odds ratio; Ref  =  reference; 95%CI  = 95% confidence interval;

\* Significant at p\<0.05.

[Table 3](#pone-0107921-t003){ref-type="table"} shows the results for allele, genotype and haplotype frequencies of *IL1A* ^−889^, *IL1B* ^−511,\ +3962^, *IL1R* ^1970^, *IL1RA* ^11100^, *IL4RA* ^+1902^, *IL12* ^−1188^, *IFNG* ^+874^, *TGFB1* ^codon\ 10,\ codon\ 25^, *TNFA* ^−308,\ −238^, *IL2* ^−330,\ +166^, *IL4* ^−1098,\ −590,\ −33^, *IL6* ^−174,\ nt565^, and *IL10* ^−1082,\ −819,\ −592^ in 138 patients sensitive to at least one of the dust mites (*D. farinae, D. pteronyssinus*, and *Blomia tropicalis*) and 116 controls.

10.1371/journal.pone.0107921.t003

###### Significant allele, genotype and haplotype frequencies of cytokine SNPs in individuals allergic to at least one of the following dust mites: *Dermatophagoides farinae*, *Dermatophagoides pteronyssinus*, and *Blomia tropicalis*, and controls.

![](pone.0107921.t003){#pone-0107921-t003-3}

                                  Patients     Controls                                                   
  ----------------------------- ------------- ---------- ------------- ------- -------- -------- -------- ------------
  ***IL1A*** **^−889^**          **n = 138**    **%**     **n = 116**   **%**   **p**    **pc**   **OR**   **95%CI**
  C/C                                80          58.0         56        48.3      ns       ns             
  T/C                                51          37.0         43        37.1      ns       ns             
  T/T                                 7          5.1          17        14.7    0.0163     ns      0.31    0.12--0.78
  C                                  211         76.4         155       66.8    0.0173     ns      1.61    1.09--2.38
  T                                  65          23.5         77        33.2    0.0173     ns      0.62    0.42--0.91
  ***IL2^−^*** ^**330,+166**^    **n = 138**    **%**     **n = 116**   **%**   **p**    **pc**   **OR**   **95%CI**
  GG/GG                               8          5.8          10         8.6      ns       ns             
  GG/TT                              26          18.8          9         7.8    0.0109     ns      2.76    1.24--6.16
  TG/GG                              33          23.9         23        19.8      ns       ns             
  TG/TG                              29          21.0         32        34.4      ns       ns             
  TG/TT                              29          21.0         36        42.9      ns       ns             
  TT/TT                              13          9.4           6         7.1      ns       ns             
  G/G^−330^                           8          5.8          10         8.6      ns       ns             
  G/T                                59          42.7         32        27.6    0.0129     ns      1.96    1.15--3.33
  T/T                                71          51.4         74        63.8      ns       ns             
  G                                  75          27.2         52        22.4      ns       ns             
  T                                  201         72.8         180       77.6      ns       ns             
  G/G^+166^                          70          50.7         65        56.0      ns       ns             
  G/T                                55          39.9         45        38.8      ns       ns             
  T/T                                13          9.4           6         5.2      ns       ns             
  G                                  195         70.6         175       75.4      ns       ns             
  T                                  81          29.3         57        24.6      ns       ns             

SNPs  =  single nucleotide polymorphisms; p =  Fisher\'s exact test with Yates\' correction; pc =  after Bonferroni correction; ns =  non-significant; OR =  odds ratio; 95%CI = 95% confidence interval.

A significant difference was observed in genotype and allele frequency between cases and controls at position −889 of the *IL1A* gene. The genotype T/T showed a negative association with sensitivity to dust mites (5.1% *vs.* 14.7%, OR = 0.31, p = 0.016, and 95% confidence interval \[95% CI\] = 0.12--0.78). An analysis of T allele variant revealed a negative association (23.5% *vs.* 33.2%, OR = 0.62, p = 0.017, and 95% CI = 0.42--0.91) with sensitivity to at least one of the three types of dust mites. The positions *IL2* ^−330,\ +166^ also showed significant frequency in the GG/TT haplotype and the G/T. The GG/TT haplotype and the G/T genotype were indicated as risk factors, with a frequency of 18.8% *vs.* 7.8% and 42.7% *vs.* 27.6% in the allergic group *vs.* the control group, respectively ([Table 3](#pone-0107921-t003){ref-type="table"}).

When comparing the frequency of cytokine SNPs between 123 patients sensitive to dust mite 1 (*D. farinae*) and 116 controls, the *IL1A* ^−889^ SNP showed a statistically significant frequency in the T/T genotype (5.7% *vs.* 14.7%, OR = 0.35, p = 0.029, and 95% CI = 0.14--0.88) and in the T allele (23.6% *vs.* 33.2%, OR = 0.62, p = 0.025, and 95% CI = 0.41--0.93), with a negative association. The *IL4RA* gene at position +1902 also showed a significant frequency in the A and G alleles. While the A allele was indicated as a risk factor, the G allele showed a protective effect, with a frequency of 74.4% *vs.* 63.8% and 25.6% *vs.* 36.2% in the allergic group *vs.* the control group, respectively. In addition, *IL2* ^−330,\ +166^ SNPs also revealed significant haplotype and genotype frequencies, indicating the GG/TT haplotype and G/T genotype as risk factors, with a frequency of 18.7% *vs.* 7.8% and 43.1% *vs.* 27.6%, respectively. The genotype TT showed a significant frequency too, with 50.4% *vs.* 63.8% in atopic group *vs.* non-atopic group, respectively. Moreover, the *IL10* ^−592^ SNP showed a statistically significant difference in the frequency of A/A (34.1% *vs.* 13.8%, OR = 3.24, p = 0.00026, pc = 0.0058, and 95% CI = 1.70--6.18) and C/A genotypes (24.4% *vs.* 46.5%, OR = 0.37, p = 0.00041, pc = 0.0090, and 95% CI = 0.21--0.64) and in the frequency of A (46.3% *vs.* 37.1%, OR = 1.47, p = 0.0418, and 95% CI = 1.02--2.11) and C alleles (53.7% *vs.* 62.9%, OR = 0.68, p = 0.0418, and 95% CI = 0.47--0.98). These data suggest that individuals who express the A allele are at risk of developing hypersensitivity to dust mite 1, and those who express the C allele have a protective factor against this development ([Table 4](#pone-0107921-t004){ref-type="table"}).

10.1371/journal.pone.0107921.t004

###### Significant allele, genotype and haplotype frequencies of cytokine SNPs in individuals allergic to dust mite 1 (*Dermatophagoides farinae*) and controls.

![](pone.0107921.t004){#pone-0107921-t004-4}

                                             Patients     Controls                                                       
  ---------------------------------------- ------------- ---------- ------------- ------- ---------- ---------- -------- ------------
  ***IL1A*** **^−889^**                     **n = 123**    **%**     **n = 116**   **%**    **p**      **pc**    **OR**   **95%CI**
  C/C                                           72          58.6         56        48.3       ns         ns              
  T/C                                           44          35.8         43        37.1       ns         ns              
  T/T                                            7          5.7          17        14.7     0.0299       ns       0.35    0.14--0.88
  C                                             188         76.4         155       66.8     0.0251       ns       1.61    1.08--2.41
  T                                             58          23.6         77        33.2     0.0251       ns       0.62    0.41--0.93
  ***IL4RA*** **^+1902^**                   **n = 123**    **%**     **n = 116**   **%**    **p**      **pc**    **OR**   **95%CI**
  A/A                                           70          56.9         52        44.8       ns         ns              
  G/A                                           43          35.0         44        37.9       ns         ns              
  G/G                                           10          8.1          20        17.2       ns         ns              
  A                                             183         74.4         148       63.8     0.0133       ns       1.65    1.11--2.44
  G                                             63          25.6         84        36.2     0.0133       ns       0.61    0.41--0.90
  ***IL2^−^*** ^**330,\ +166**^             **n = 123**    **%**     **n = 116**   **%**    **p**      **pc**    **OR**   **95%CI**
  GG/GG                                          7          5.7          10         8.6       ns         ns              
  GG/TT                                         23          18.7          9         7.8     0.0139       ns       2.73    1.21--6.19
  GT/GT                                          1          0.8           0          0        ns         ns              
  TG/GG                                         29          23.6         23        19.8       ns         ns              
  TG/GT                                          1          0.8           0          0        ns         ns              
  TG/TG                                         25          20.3         32        34.4       ns         ns              
  TG/TT                                         27          21.9         36        42.9       ns         ns              
  TT/TT                                         10          8.1           6         7.1       ns         ns              
  G/G^−330^                                      8          6.5          10         8.6       ns         ns              
  G/T                                           53          43.1         32        27.6     0.0149       ns       1.99    1.16--3.41
  T/T                                           62          50.4         74        63.8     0.0497       ns       0.58    0.34--0.97
  G                                             69          28.0         52        22.4       ns         ns              
  T                                             177         71.9         180       77.6       ns         ns              
  G/G^+166^                                     61          49.6         65        56.0       ns         ns              
  G/T                                           51          41.5         45        38.8       ns         ns              
  T/T                                           11          8.9           6         5.2       ns         ns              
  G                                             173         70.3         175       75.4       ns         ns              
  T                                             73          29.7         57        24.6       ns         ns              
  ***IL10^−^*** ^**1082,\ −819,\ −592**^    **n = 123**    **%**     **n = 116**   **%**    **p**      **pc**    **OR**   **95%CI**
  ACA/ACA                                        1          0.8           1         0.9       ns         ns              
  ACC/ACC                                        6          4.9           3         2.6       ns         ns              
  ACC/ATA                                       24          19.5         28        24.1       ns         ns              
  ATA/ATA                                       17          13.8         14        15.9       ns         ns              
  GCC/ACC                                       36          29.3         38        37.2       ns         ns              
  GCC/ATA                                       29          23.6         23        29.5       ns         ns              
  GCC/GCC                                        8          6.5           5         6.4       ns         ns              
  ACA/ATA                                        0           0            1         0.9       ns         ns              
  ACC/ACA                                        1          0.8           1         0.9       ns         ns              
  ATC/ATA                                        0           0            2         1.8       ns         ns              
  ACC/ATC                                        1          0.8           0          0        ns         ns              
  A/A^−1082^                                    50          40.6         50        43.1       ns         ns              
  G/A                                           65          52.8         61        52.6       ns         ns              
  G/G                                            8          6.5           5         4.3       ns         ns              
  A                                             165         67.1         161       69.4       ns         ns              
  G                                             81          32.9         71        30.6       ns         ns              
  C/C^−819^                                     52          42.3         48        41.4       ns         ns              
  C/T                                           54          43.9         52        44.8       ns         ns              
  T/T                                           17          13.8         16        13.8       ns         ns              
  C                                             158         64.2         148       63.8       ns         ns              
  T                                             88          35.8         84        36.2       ns         ns              
  A/A^−592^                                     42          34.1         16        13.8    0.000268   0.005896    3.24    1.70--6.18
  C/A                                           30          24.4         54        46.5    0.00041    0.00902     0.37    0.21--0.64
  C/C                                           51          41.5         46        39.7       ns         ns              
  A                                             114         46.3         86        37.1     0.0418       ns       1.47    1.02--2.11
  C                                             132         53.7         146       62.9     0.0418       ns       0.68    0.47--0.98

SNPs  =  single nucleotide polymorphisms; p =  Fisher\'s exact test with Yates\' correction; pc =  after Bonferroni correction; ns =  non-significant; OR =  odds ratio; 95%CI = 95% confidence interval.

The analysis of the frequency of cytokine SNPs in 98 individuals sensitive to dust mite 2 (*D. pteronyssinus*) and 116 controls showed a significant difference in *IL2* ^−330,\ +166^ SNPs in the GG/TT haplotype (18.4% *vs.* 7.8%, OR = 2.67, p = 0.0234, and 95% CI = 1.14--6.26) and in the G/T genotype (42.9% *vs.* 27.6%, OR = 1.97, p = 0.0215, and 95% CI = 1.11--3.48). A positive association with sensitivity to dust mite 2 was found only at position −330. There was also a significant statistical difference in the *IL4* ^−590^ SNP when analyzing the distribution of genotypic and allelic variants. The T/C genotype (10.2% *vs.* 43.1%, OR = 0.15, p = 0.000000052, pc = 0.0000011, and 95% CI = 0.07--0.32) showed a negative association with sensitivity to dust mite 2, while the T/T genotype (42.9% *vs.* 13.8%, OR = 4.69, p = 0.0000025, pc = 0.000055, and 95% CI = 2.42--9.09) showed a positive association. Additionally, C and T alleles were indicated as protective and risk factors, respectively, for the development of sensitivity to dust mite 2, with a frequency of 52.0% *vs.* 64.7% and 48.0% *vs.* 35.3%, respectively ([Table 5](#pone-0107921-t005){ref-type="table"}).

10.1371/journal.pone.0107921.t005

###### Significant allele, genotype and haplotype frequencies of cytokine SNPs in individuals allergic to dust mite 2 (*Dermatophagoides pteronyssinus*) and controls.
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                                         Patients    Controls                                                             
  ------------------------------------ ------------ ---------- ------------- ------- ------------- ------------- -------- ------------
  ***IL2^−^*** ^**330,\ +166**^         **n = 98**    **%**     **n = 116**   **%**      **p**        **pc**      **OR**   **95%CI**
  GG/GG                                     6          6.1          10         8.6        ns            ns                
  GG/TT                                     18         18.4          9         7.8      0.0234          ns         2.67    1.14--6.26
  TG/GG                                     23         23.5         23        19.8        ns            ns                
  TG/GT                                     1          1.0           0          0         ns            ns                
  TG/TG                                     19         19.4         32        34.4        ns            ns                
  TG/TT                                     21         21.4         36        42.9        ns            ns                
  TT/TT                                     10         10.2          6         7.1        ns            ns                
  G/G^−330^                                 6          6.1          10         8.6        ns            ns                
  G/T                                       42         42.9         32        27.6      0.0215          ns         1.97    1.11--3.48
  T/T                                       50         51.0         74        63.8        ns            ns                
  G                                         54         27.5         52        22.4        ns            ns                
  T                                        142         72.4         180       77.6        ns            ns                
  G/G^+166^                                 48         49.0         65        56.0        ns            ns                
  G/T                                       40         40.8         45        38.8        ns            ns                
  T/T                                       10         10.2          6         5.2        ns            ns                
  G                                        136         69.4         175       75.4        ns            ns                
  T                                         60         30.6         57        24.6        ns            ns                
  ***IL4*** **^−1098,\ −590,\ −33^**    **n = 98**    **%**     **n = 116**   **%**      **p**        **pc**      **OR**   **95%CI**
  GCC/GCC                                   1          1.0           2         1.7        ns            ns                
  GTT/GTT                                   1          1.0           0          0         ns            ns                
  TCC/GCC                                   11         11.2         10         8.6        ns            ns                
  TCC/TCC                                   34         34.7         38        35.8        ns            ns                
  TTC/TCC                                   5          5.1           7         9.0        ns            ns                
  TTC/TTC                                   2          2.0           0          0         ns            ns                
  TTT/GCC                                   3          3.1          11        14.1        ns            ns                
  TTT/TCC                                   27         27.5         30        28.6        ns            ns                
  TTT/TTC                                   4          4.1           3         3.5        ns            ns                
  TTT/TTT                                   7          7.1           9        10.5        ns            ns                
  GTC/GTC                                   0           0            1         0.9        ns            ns                
  GTT/GCC                                   0           0            1         0.9        ns            ns                
  GTT/GTC                                   0           0            1         0.9        ns            ns                
  TTT/GTC                                   0           0            1         0.9        ns            ns                
  TTT/GTT                                   1          1.0           1         0.9        ns            ns                
  TTC/GCC                                   2          2.0           1         0.9        ns            ns                
  G/G^−1098^                                2          2.0           5         4.3        ns            ns                
  T/G                                       17         17.3         24        20.7        ns            ns                
  T/T                                       79         80.6         87        75.0        ns            ns                
  G                                         21         10.7         34        14.7        ns            ns                
  T                                        175         89.3         198       85.3        ns            ns                
  C/C^−590^                                 46         46.9         50        43.1        ns            ns                
  T/C                                       10         10.2         50        43.1    0.000000052   0.000001144    0.15    0.07--0.32
  T/T                                       42         42.9         16        13.8     0.0000025     0.000055      4.69    2.42--9.09
  C                                        102         52.0         150       64.7      0.0103          ns         0.59    0.40--0.87
  T                                         94         48.0         82        35.3      0.0103          ns         1.68    1.14--2.49
  C/C^−33^                                  55         56.1         59        50.9        ns            ns                
  T/C                                       34         34.7         47        40.5        ns            ns                
  T/T                                       9          9.2          10         8.6        ns            ns                
  C                                        144         73.5         165       71.1        ns            ns                
  T                                         52         26.5         67        28.9        ns            ns                

SNPs  =  single nucleotide polymorphisms; p =  Fisher\'s exact test with Yates\' correction; pc =  after Bonferroni correction; ns =  non-significant; OR =  odds ratio; 95%CI = 95% confidence interval.

A total of 103 individuals were sensitive to dust mite 3 (*Blomia tropicalis*). The *IL2* ^−330,\ +166^ SNPs showed a significant frequency in the GG/TT haplotype (17.5% *vs.* 7.8%, OR = 2.52, p = 0.0387, and 95% CI = 1.08--5.89), being a risk factor for the development of sensitivity to dust mite 3 ([Table 6](#pone-0107921-t006){ref-type="table"}).

10.1371/journal.pone.0107921.t006

###### Significant allele, genotype and haplotype frequencies of cytokine SNPs in individuals allergic to dust mite 3 (*Blomia tropicalis*) and controls.
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               Patients          Controls                              
  ----------- ---------- ------ ---------- ------ -------- ---- ------ ------------
  GG/GG           7       6.8       10      8.6      ns     ns         
  GG/TT           18      17.5      9       7.8    0.0387   ns   2.52   1.08--5.89
  TG/GG           22      21.4      23      19.8     ns     ns         
  TG/GT           1       1.0       0        0       ns     ns         
  TG/TG           18      17.5      32      34.4     ns     ns         
  TG/TT           25      24.3      36      42.9     ns     ns         
  TT/TT           12      11.6      6       7.1      ns     ns         
  G/G^−330^       7       6.8       10      8.6      ns     ns         
  G/T             41      39.8      32      27.6     ns     ns         
  T/T             55      53.4      74      63.8     ns     ns         
  G               55      26.7      52      22.4     ns     ns         
  T              151      73.3     180      77.6     ns     ns         
  G/G^+166^       47      45.6      65      56.0     ns     ns         
  G/T             44      42.7      45      38.8     ns     ns         
  T/T             12      11.6      6       5.2      ns     ns         
  G              138      67.0     175      75.4     ns     ns         
  T               68      33.0      57      25.6     ns     ns         

SNPs  =  single nucleotide polymorphisms; p =  Fisher\'s exact test with Yates\' correction; pc =  after Bonferroni correction; ns =  non-significant; OR =  odds ratio; 95%CI = 95% confidence interval.

As for the influence of regulatory regions on cytokine production, we found no significant difference in the association of *TGFB1*, *TNFA* and *IL10* genotypes and haplotypes between cases and controls as selected using the Cytokine Genotyping Kit (Invitrogen).

Discussion {#s4}
==========

Allergy is a multifactorial condition, with the onset and severity dependent on genetic and environmental factors. Hypersensitivity to house dust mites may trigger different cutaneous and respiratory responses, which have a great impact on the health of affected individuals [@pone.0107921-Shin1].

The discoveries made in the 1950s about the mechanisms of gene regulation in prokaryotes, such as lac or lambda repressor, have allowed researchers to investigate DNA binding sites in the regulatory regions of eukaryotes. Since then, several regulatory regions have been detected upstream and downstream of the transcribed gene, mainly in SNP regions.

The development of molecular biology techniques has allowed the identification of genetic polymorphisms within regulatory regions of cytokine genes, and also the finding that the level of cytokine production differs among individuals. These considerations have prompted many authors to investigate the regulation of genes expressing these cytokines in relation to susceptibility to and severity of different diseases [@pone.0107921-Hollegaard1], [@pone.0107921-Bidwell1]. Although cytokines are usually related to allergic diseases, such as allergic rhinitis, allergic conjunctivitis, food allergy, atopic dermatitis, and asthma, they have been suggested as important biomarkers of various diseases, such as lupus erythematosus, pediatric ulcerative colitis [@pone.0107921-Ngoc1], [@pone.0107921-Wine1], [@pone.0107921-Postal1], Alzheimer\'s disease [@pone.0107921-Du1], [@pone.0107921-Grimaldi1], [@pone.0107921-Nicoll1], and ankylosing spondylitis [@pone.0107921-Goedecke1].

There is an increasing number of studies devoted to this topic in the international literature. However, to date, there are no studies conducted in Brazil that address this issue. A cohort study of asthma in the Korean population suggested a possible involvement of *IL18* polymorphisms in asthma [@pone.0107921-Shin1]. A study involving 417 Costa Rican children and 503 children participating in a childhood asthma management program showed significant changes in the interaction between IgE and dust mite allergens at three *IL10* SNP positions (rs1800896, rs3024492, and rs3024496), suggesting that exposure to these allergens significantly modified the effect of *IL10* SNPs [@pone.0107921-Hunninghake1]. Recently, higher serum levels of *TNFA* have been found in genotypes G/A and G/G of asthmatic children compared to controls (60.0% *vs.* 30%) [@pone.0107921-Shaker1].

There is considerable evidence associating interleukins and somatic complaints. Thompson and Barkhuizen [@pone.0107921-Thompson1] reported on alterations of *IL2*, *IL2* receptor (*IL2R*), *IL8*, and *IL1* receptor antagonist (*IL1RA*) in fibromyalgia and described the mechanism by which alterations in cytokines (in fibromyalgia and hepatitis C) may trigger hyperalgesia and other symptoms mediated by the presence of cytokine receptors on certain cells. They also pointed out the role of other cytokines, such as *IL6*, *IL10*, and *TNFA* in the relationship between chronic inflammation and mortality. A study carried out in Boston with 183 patients on hemodialysis showed a strong association between SNPs (*IL6* ^−174^, *IL10* ^−1082^, and *TNFA* ^−308^) and patients with end-stage renal disease [@pone.0107921-Balakrishnan1].

Moreover, cytokines play an important physiological role in immune regulation and inflammatory processes, and changes in the aberrant expression or failure in production may contribute to the development of certain diseases [@pone.0107921-Meenagh1], [@pone.0107921-Pravica1], [@pone.0107921-Fishman1], [@pone.0107921-Turner1]. Because of the influence on cytokine production, these polymorphisms may provide flexibility to the immune response. In addition, the balance between pro- and anti-inflammatory cytokines is known to determine the intensity of inflammatory response [@pone.0107921-Rao1].

The present results showed an important association between SNPs in cytokine genes and susceptibility to or protection from allergy to dust mites in *IL1A* at position −889, *IL4RA* at position +1902, *IL2* at positions −330 and +166, *IL4* at position −590, and *IL10* at position −592. All *loci* showed a gene frequency distribution in accordance with expected frequencies after calculating HWE, whose p-values were greater than the significance level of 0.05, *IL12* at position −1188 and *IL10* at position −1082. Considering that no evolutionary factor (mutation, migration, drift, or selection) was observed in this study, there may have been an error in the interpretation of the results. In order to avoid a type I error, the analyses of these two *loci* were excluded.

*IL1A* is synthesized by different cell types, such as activated macrophages and B lymphocytes, and by non-immune cells, such as fibroblasts. In addition, this cytokine is considered a potent inflammatory mediator and is located on chromosome 2q13 in humans [@pone.0107921-Lord1]. Karjalainen *et al.* [@pone.0107921-Karjalainen1] conducted a study of 245 asthmatic adults and 405 controls associating the *IL1A* genotype with atopy in non asthmatic adults. No significant association was found between *IL1A* genotypes and skin test findings in asthmatic patients. Among controls, however, the *IL1A* genotype distribution was significantly different (p = 0.006) in individuals with positive (n = 150) and negative (n = 247) skin test responses. In our study, the T/T genotype and T allele of *IL1A* gene (rs1800587) were associated with protection against dust mite allergy (OR, 0.31 and 0.62 respectively) when cases were compared to controls. Conversely, the C allele was positively associated with disease (OR, 1.61).

In a German study [@pone.0107921-Jongh1], the *IL1A* −889 T allele was also associated with a protective effect, with a lower prevalence of dermatitis in a group exposed to a high risk of skin irritability. In that same study, the authors investigated the association between the *IL1A* −889 SNP and *IL1* cytokine levels in the stratum corneum. The *IL1* concentration was 23% and 47% lower in subjects with *IL1A* C/T and T/T genotypes, respectively, when compared to the C/C genotype. The reduced subcutaneous level of this pro-inflammatory cytokine for *IL1A* −889 T allele would explain the protective effect of this allele against dermatitis.

*IL2*, located on chromosome 4q27 in humans, is considered a key lymphokine, responsible for triggering the proliferation of Ly-T cells after interaction with peptide presentation [@pone.0107921-Lowenthal1], [@pone.0107921-Smith1], which consequently stimulates Th2 responses and antibody production. Due to this central role in regulating the immune response, *IL2* is considered a strong candidate gene for allergic disease. Christensen *et al.* [@pone.0107921-Christensen1] investigated the involvement of *IL2* and *IL15* in the etiology of atopy and allergic diseases in a family-based association study of two Danish samples comprising a total of 235 families with at least two siblings with allergic disease. *IL2* at position −330 showed a significant association with three clinical forms of allergic disease (asthma, allergic rhinitis, and atopic dermatitis) in the group with 135 families, with p-values between 0.01 and 0.05, and *IL2* at position +166 also showed a significant association (with a p-value of 0.0005) in the same group. *IL15* showed no significant association.

SNP at position +166 does not alter *IL2* expression, because it does not interfere with the amino acid sequence, i.e., it is a silent mutation [@pone.0107921-Franceschi1]. Therefore, the association occurs only at position −330.

Differences in cytokine production between allelic variants and their corresponding phenotypes were compared using Jonckheere\'s trend test for high, intermediate, and low comparisons. Individuals that were homozygous for the G allele produced over three times the amount of *IL2* than the T/T and T/G genotypes (p\<0.001) [@pone.0107921-Hoffmann1]. In the present study, we observed significant differences in the frequency of the G/T and T/T genotypes, which are associated with low *IL2* production. The mechanism by which this is accomplished is currently under study. Given its influence on cell cycle advancement and apoptosis, much attention has been focused on the events that regulate *IL2* signal transduction. It is possible that the polymorphism at position −330 interferes with the binding of a key silencer element, thereby resulting in enhanced (or not) *IL2* production [@pone.0107921-Hoffmann1].

*IL4* and *IL4RA* are candidate genes for atopic diseases, i.e., diseases that are clinically expressed as atopic asthma, allergic rhinitis, and atopic dermatitis or that can be defined by at least one positive specific IgE response to inhalant or food allergens [@pone.0107921-Lu1], [@pone.0107921-Micheal1]. A case-control study of 265 patients with persistent allergic rhinitis and 275 healthy controls revealed that the C/T and C/C genotypes in *IL4* ^−590^ were associated with a significantly decreased risk of mite-sensitized persistent allergic rhinitis (32.5% *vs.* 42.9%, OR = 0.64, 95%CI = 0.45-0.92) compared to the T/T genotype [@pone.0107921-Lu1]. In the current study, a highly significant association was observed between the frequency of *IL4* ^−590^ SNP in 98 individuals allergic to *D. pteronyssinus* and 116 controls and the T/C genotype (p = 0.000000052) and the C allele (p = 0.010), suggesting a protective effect against sensitization to dust mites.

However, there are conflicting reports in the literature. Micheal *et al.* [@pone.0107921-Micheal1], in a case-control study of 214 atopic patients (108 with asthma and 106 with allergic rhinitis), found that the T/T genotype in the SNP rs2243250 was significantly associated with asthma (p  =  0.004) and allergic rhinitis (p \<0.001), but playing a protective role rather than predisposing to respiratory allergy, as demonstrated by our data for the same genotype (p  =  0.0000025). Our results are consistent with findings of studies conducted in China [@pone.0107921-Lu1], India [@pone.0107921-Vishnumaya1], and Iran [@pone.0107921-HosseiniFarahabadi1].

In Germany, Liu *et al.* [@pone.0107921-Liu1] conducted a case-control study to examine the increased risk of sensitization to food, dust mites, cat epithelium, and outdoor allergens (e.g., pollen) in six SNPs (C-590T in the *IL4* gene, C-1055T and Arg130Gln in the *IL13* gene, and Ile50Val, Ser478Pro, and Gln551Arg in the *IL4RA* gene) and reported that, as for sensitization to dust mites, tests performed with 108 sensitized children and 432 controls revealed no significant association between sensitization to dust mite allergens and the six SNPs. Their findings disagree with our results for the *IL4RA* SNP (rs1801275), which expressed the A allele as a risk factor (OR, 1.65) and the G allele as a protective factor (OR, 0.61). It is worth noting that significant differences were observed between allele frequencies only for dust mite 1 (*D. farinae*), even after Bonferroni correction. No differences were observed in the genotypes at this position, probably due to the low risk obtained for these alleles.

The *IL10* ^−592^ gene was significantly different both for the A/A (OR, 3.24) and C/A (OR, 0.37) genotypes and for the A (OR, 1.47) and C (OR, 0.68) alleles. In Costa Rica, a study of 417 children and 503 participants of a childhood asthma management program highlighted the role of *IL10* in allergy and asthma exacerbations (when exposed to dust mites). Using a family-based approach to test for associations, the results showed that exposure to house dust mite allergens led to significant differences in the *IL10* gene [@pone.0107921-Hunninghake1].

So far, the present discussion has been based on the data considered significant as compared with those obtained from similar studies. However, because of the paucity of specific studies, we applied the Bonferroni correction to our data to avoid type II errors. After this correction, only *IL10* at position −592 for *D. farinae* and *IL4* at position −590 for *D. pteronyssinus* remained significant. These findings may suggest that different causative agents may be regulated by different cytokine production pathways, and that both cytokines have a biological role in controlling the production of different classes of antibodies. We believe that these data will add useful evidence to this line of research.

Conclusions {#s5}
===========

Our results suggest an association of allelic and genotypic variants in the pro-inflammatory cytokines *IL1A* ^−889^ and *IL2* ^−330^ and anti-inflammatory cytokines *IL4* ^−590^, *IL4RA* ^+1902^ and *IL10* ^−592^.

The detection of candidate genes in individuals sensitive to dust mites may reveal mechanisms of interaction between allergies and hosts, and this detection allows the development of new preventive, diagnostic and therapeutic strategies. Thus, further studies are needed to clarify the role of these genetic markers in the susceptibility to and/or protection against house dust mite sensitivity.
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